Trademark: 87822368
Word
CULMINATION
Status
Registered
Status Code
700
Status Date
Tuesday, April 5, 2022
Serial Number
87822368
Registration Number
6694431
Registration Date
Tuesday, April 5, 2022
Mark Type
4000
Filing Date
Tuesday, March 6, 2018
Published for Opposition
Tuesday, January 1, 2019

Trademark Owner History
Culmination, Inc. - Original Registrant

Classifications
44 Gene and human tissue bank services in the nature of biological asset bank repository services for DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens; isolation, collection, preservation and banking of biological assets, namely, DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; medical analysis of biological assets, namely, DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens, for medical diagnostic and treatment purposes; providing a website featuring medical information in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; providing online non-downloadable searchable databases and non-searchable databases featuring medical information in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; providing medical information in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; genetic analysis services in the nature of genetic testing for medical purposes; and cell, cell line, tissue, tissue line and bodily fluid analysis services in the nature of genetic testing for medical purposes
42 Medical research and analysis services, namely, medical laboratory research and medical laboratory services; biological research and analysis services; genetic analysis services in the nature of genetic testing for scientific research purposes; cell, cell line, tissue, tissue line and bodily fluid analysis services in the nature of medical laboratory research for scientific research purposes; scientific laboratory services in the fields of medical, health and biological data analysis; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; providing medical research and scientific research information in the fields of pathology, pharmacology, immunology, bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; preparation of biological samples for research purposes; medical laboratory services; medical and scientific laboratory services for collecting, incubating, growing, controlling, processing, analyzing, transporting and storing biological samples; operating and maintaining a biorepository for medical and scientific research purposes; laboratory services, namely, isolation, archival storage and chain-of-custody management of DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens for others; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenomics; research and development services in the nature of creating libraries and collections of DNA, RNA, cells, cell lines, tissue, tissue lines, formalin-fixed paraffin-embedded tissue, and bodily fluid specimens; computer modeling services; and computer simulation based on computer programs for others; providing online non-downloadable software for the collection, storage, management, organization, analysis, and display of data in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling for medical diagnostic and treatment research purposes; software as a service services featuring software for the collection, storage, management, organization, analysis, and display of data in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling for medical diagnostic and treatment research purposes; providing an online computer database for medical and scientific researchers in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; and development of computer software and hardware for use in medical, health and biological data analysis; analyzing and compiling data for research purposes in the field of medical science and medical consultancy; and compilation, systemization and administration of medical, health and biological data for research purposes via computer apparatus and computer databases

Trademark Events
Apr 5, 2022
Registered-Principal Register
Mar 3, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 2, 2022
Allowed Principal Register - Sou Accepted
Mar 1, 2022
Statement Of Use Processing Complete
Feb 27, 2022
Use Amendment Filed
Feb 27, 2022
Teas Statement Of Use Received
Aug 27, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 26, 2021
Sou Extension 5 Granted
Aug 24, 2021
Sou Extension 5 Filed
Aug 26, 2021
Case Assigned To Intent To Use Paralegal
Aug 24, 2021
Sou Teas Extension Received
Feb 27, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 25, 2021
Sou Extension 4 Granted
Feb 25, 2021
Sou Extension 4 Filed
Feb 25, 2021
Sou Teas Extension Received
Aug 25, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 21, 2020
Sou Extension 3 Granted
Aug 21, 2020
Sou Extension 3 Filed
Aug 21, 2020
Sou Teas Extension Received
Feb 26, 2020
Notice Of Approval Of Extension Request E-Mailed
Feb 24, 2020
Sou Extension 2 Granted
Feb 24, 2020
Sou Extension 2 Filed
Feb 24, 2020
Sou Teas Extension Received
Feb 24, 2020
Teas Change Of Correspondence Received
Feb 24, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 24, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 24, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 24, 2020
Teas Change Of Owner Address Received
Jul 2, 2019
Teas Change Of Correspondence Received
Jul 4, 2019
Notice Of Approval Of Extension Request E-Mailed
Jul 2, 2019
Sou Extension 1 Granted
Jul 2, 2019
Sou Extension 1 Filed
Jul 2, 2019
Sou Teas Extension Received
Feb 26, 2019
Noa E-Mailed - Sou Required From Applicant
Jan 1, 2019
Official Gazette Publication Confirmation E-Mailed
Jan 1, 2019
Published For Opposition
Dec 12, 2018
Notification Of Notice Of Publication E-Mailed
Nov 26, 2018
Assigned To Lie
Nov 6, 2018
Approved For Pub - Principal Register
Nov 6, 2018
Examiner's Amendment Entered
Nov 6, 2018
Notification Of Examiners Amendment E-Mailed
Nov 6, 2018
Examiners Amendment E-Mailed
Nov 6, 2018
Examiners Amendment -Written
Nov 5, 2018
Teas/Email Correspondence Entered
Nov 4, 2018
Correspondence Received In Law Office
Nov 4, 2018
Teas Response To Office Action Received
Jun 28, 2018
Notification Of Non-Final Action E-Mailed
Jun 28, 2018
Non-Final Action E-Mailed
Jun 28, 2018
Non-Final Action Written
Jun 18, 2018
Assigned To Examiner
Mar 13, 2018
New Application Office Supplied Data Entered
Mar 9, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24